Effect of Folic Acid Supplementation in Pregnancy on Preeclampsia: The Folic Acid Clinical Trial Study

Preeclampsia (PE) is hypertension with proteinuria that develops during pregnancy and affects at least 5% of pregnancies. The Effect of Folic Acid Supplementation in Pregnancy on Preeclampsia: the Folic Acid Clinical Trial (FACT) aims to recruit 3,656 high risk women to evaluate a new prevention strategy for PE: supplementation of folic acid throughout pregnancy. Pregnant women with increased risk of developing PE presenting to a trial participating center between 80/7 and 166/7 weeks of gestation are randomized in a 1 : 1 ratio to folic acid 4.0 mg or placebo after written consent is obtained. Intent-to-treat population will be analyzed. The FACT study was funded by the Canadian Institutes of Health Research in 2009, and regulatory approval from Health Canada was obtained in 2010. A web-based randomization system and electronic data collection system provide the platform for participating centers to randomize their eligible participants and enter data in real time. To date we have twenty participating Canadian centers, of which eighteen are actively recruiting, and seven participating Australian centers, of which two are actively recruiting. Recruitment in Argentina, UK, Netherlands, Brazil, West Indies, and United States is expected to begin by the second or third quarter of 2013. This trial is registered with NCT01355159.

[1]  Zhiwen Li,et al.  Folic Acid Supplementation During Early Pregnancy and the Risk of Gestational Hypertension and Preeclampsia , 2013, Hypertension.

[2]  R. Oster,et al.  Meta-analysis of cancer risk in folic acid supplementation trials. , 2012, Cancer epidemiology.

[3]  S. Smeland,et al.  Cancer risk with folic acid supplements: a systematic review and meta-analysis , 2012, BMJ Open.

[4]  A. Czeizel,et al.  Birth Outcomes of Newborns after Folic Acid Supplementation in Pregnant Women with Early and Late Pre-Eclampsia: A Population-Based Study , 2010, Advances in preventive medicine.

[5]  R. Collins,et al.  Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. , 2010, Archives of internal medicine.

[6]  R. Collins,et al.  Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. , 2010, JAMA.

[7]  F. Martel,et al.  Folic acid uptake by the human syncytiotrophoblast: interference by pharmacotherapy, drugs of abuse and pathological conditions. , 2009, Reproductive toxicology.

[8]  S. Vollset,et al.  Cancer incidence and mortality after treatment with folic acid and vitamin B12. , 2009, JAMA.

[9]  J. Olsen,et al.  Association of periconceptional multivitamin use with reduced risk of preeclampsia among normal-weight women in the Danish National Birth Cohort. , 2009, American journal of epidemiology.

[10]  M. Aral,et al.  Association of Maternal Serum CRP, IL-6, TNF-α, Homocysteine, Folic Acid and Vitamin B12 Levels with the Severity of Preeclampsia and Fetal Birth Weight , 2009, Hypertension in pregnancy.

[11]  W. Fraser,et al.  Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes , 2008, Canadian Medical Association Journal.

[12]  Young-In Kim.  Folic Acid Supplementation and Cancer Risk: Point , 2008, Cancer Epidemiology Biomarkers & Prevention.

[13]  V. Désilets,et al.  Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. , 2007, Journal of Obstetrics and Gynaecology Canada.

[14]  Elizabeth L. Barry,et al.  Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. , 2007, JAMA.

[15]  S. Larsson,et al.  Folate and risk of breast cancer: a meta-analysis. , 2007, Journal of the National Cancer Institute.

[16]  I. Blair,et al.  Mild folate deficiency induces a proatherosclerotic phenotype in endothelial cells. , 2006, Atherosclerosis.

[17]  S. Neubauer,et al.  5-Methyltetrahydrofolate Rapidly Improves Endothelial Function and Decreases Superoxide Production in Human Vessels: Effects on Vascular Tetrahydrobiopterin Availability and Endothelial Nitric Oxide Synthase Coupling , 2006, Circulation.

[18]  R. Ness,et al.  Periconceptional multivitamin use reduces the risk of preeclampsia. , 2006, American journal of epidemiology.

[19]  E. Wiltshire,et al.  Folate and Vitamin B6 Rapidly Normalize Endothelial Dysfunction In Children With Type 1 Diabetes Mellitus , 2006, Pediatrics.

[20]  K. Bønaa,et al.  Homocysteine lowering and cardiovascular events after acute myocardial infarction. , 2006, The New England journal of medicine.

[21]  G. R. Rosa Díez,et al.  Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate–advanced chronic renal failure , 2006, Nephrology.

[22]  Joseph Su,et al.  Effects of Riboflavin and Folic Acid Supplementation on Plasma Homocysteine Levels in Healthy Subjects , 2006, The American journal of the medical sciences.

[23]  A. Ekström,et al.  Folate, vitamin B12, and homocysteine levels in South Asian women with growth‐retarded fetuses , 2005, Acta obstetricia et gynecologica Scandinavica.

[24]  W. Fawzi,et al.  Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension. , 2005, The Journal of nutrition.

[25]  G. Davey Smith,et al.  Taking folate in pregnancy and risk of maternal breast cancer , 2005, BMJ : British Medical Journal.

[26]  Kirsten Duckitt,et al.  Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies , 2005, BMJ : British Medical Journal.

[27]  G. Smith,et al.  Folic acid supplements in pregnancy and birth outcome: re-analysis of a large randomised controlled trial and update of Cochrane review. , 2005, Paediatric and perinatal epidemiology.

[28]  J. Mandel,et al.  Folic acid fortification remains an urgent health priority , 2004, BMJ : British Medical Journal.

[29]  G. Smith,et al.  Taking folate in pregnancy and risk of maternal breast cancer , 2004, BMJ : British Medical Journal.

[30]  G. Prescott,et al.  Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study , 2003, BMJ : British Medical Journal.

[31]  A. Trumble,et al.  Severe Maternal Morbidity Associated with Hypertensive Disorders in Pregnancy in the United States , 2003, Hypertension in pregnancy.

[32]  S. Hernández-Díaz,et al.  Risk of gestational hypertension in relation to folic acid supplementation during pregnancy. , 2002, American journal of epidemiology.

[33]  J. Roberts,et al.  Recent Insights into the pathogenesis of pre-eclampsia. , 2002, Placenta.

[34]  R. T. Lie,et al.  Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. , 2001, BMJ : British Medical Journal.

[35]  M. Faas,et al.  Etiology and pathogenesis of preeclampsia: current concepts. , 1999, American journal of obstetrics and gynecology.

[36]  A. Czeizel,et al.  Acute toxicity of folic acid in pregnant women. , 1999, Teratology.

[37]  R. Ness,et al.  Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. , 1998, American journal of obstetrics and gynecology.

[38]  S F Bottoms,et al.  The preterm prediction study: risk factors for indicated preterm births. Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development. , 1998, American journal of obstetrics and gynecology.

[39]  R. Grunau,et al.  Extremely premature (⩽ 800 g) schoolchildren: multiple areas of hidden disability , 1997, Archives of disease in childhood. Fetal and neonatal edition.

[40]  A. Czeizel,et al.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. , 1992, The New England journal of medicine.

[41]  L. Duley.  Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean , 1992, British journal of obstetrics and gynaecology.

[42]  M. Gnant,et al.  Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.

[43]  Stanley Lemeshow,et al.  Adequacy of Sample Size in Health Studies , 1990 .

[44]  K. Laurence,et al.  Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. , 1981, British medical journal.

[45]  C. Schorah,et al.  Vitamin dificiencies and neural tube defects. , 1976, Archives of disease in childhood.

[46]  T. Prankerd,et al.  THE VALUE OF FOLIC ACID SUPPLEMENTS IN PREGNANCY , 1971, The Journal of obstetrics and gynaecology of the British Commonwealth.

[47]  C. Carter,et al.  Major central nervous system malformations in South Wales. II. Pregnancy factors, seasonal variation, and social class effects. , 1968, British journal of preventive & social medicine.

[48]  A. Fleming,et al.  THE PREVENTION OF MEGALOBLASTIC ANAEMIA IN PREGNANCY IN NIGERIA , 1968, The Journal of obstetrics and gynaecology of the British Commonwealth.

[49]  R. Smithells,et al.  FOLIC ACID METABOLISM AND HUMAN EMBRYOPATHY , 1965 .

[50]  T. Labrum,et al.  Congenital malformations of the central nervous system. , 1961, Obstetrics and gynecology.

[51]  J. Thiersch.  Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A) administered by the oral route. , 1952, American journal of obstetrics and gynecology.

[52]  T. Mckeown,et al.  Congenital Malformations of the Central Nervous System , 1949 .

[53]  W. Marsden.  I and J , 2012 .

[54]  A. Hofman,et al.  Folic acid is positively associated with uteroplacental vascular resistance: the Generation R study. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[55]  R. Sigal,et al.  Folic acid supplementation in early second trimester and the risk of preeclampsia. , 2008, American journal of obstetrics and gynecology.

[56]  R. Obeid,et al.  Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status , 2005, Clinical chemistry and laboratory medicine.

[57]  D. Wlody,et al.  Hypertension in pregnancy. , 1992, The New England journal of medicine.

[58]  D. Cockroft.  Vitamin deficiencies and neural-tube defects: human and animal studies. , 1991, Human reproduction.

[59]  K. Aleš,et al.  Development and validation of a multivariate predictor of mortality in very low birth weight. , 1988, Journal of clinical epidemiology.

[60]  I. Miyazaki,et al.  AND T , 2022 .

[61]  and as an in , 2022 .